Lista de obras -

A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.

artículo científico publicado en 2018

A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene

artículo científico publicado en 2002

A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiency

artículo científico publicado en 2013

Advances in the diagnosis and management of type 1 von Willebrand disease ⬇️

artículo científico publicado el 1 de febrero de 2011

Assessing bleeding in von Willebrand disease with bleeding score

artículo científico publicado en 2006

Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?

artículo científico publicado en 2013

Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.

artículo científico publicado en 2013

Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.

artículo científico publicado en 2017

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

artículo científico publicado en 2016

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia

artículo científico publicado en 2014

Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation

artículo científico publicado en 2013

Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults

artículo científico publicado en 2004

Economic assessment of eltrombopag in the treatment of thrombocytopenia

artículo científico publicado en 2015

Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome

artículo científico publicado en 2016

First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat

artículo científico publicado en 2008

Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases

artículo científico publicado en 2008

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

artículo científico publicado en 2016

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature

artículo científico publicado en 2008

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from literature analysis

artículo científico publicado en 2006

How I treat von Willebrand disease

artículo científico publicado en 2009

ITP and international guidelines: what do we know, what do we need?

artículo científico publicado en 2014

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

artículo científico publicado en 2008

Immune thrombocytopenia in lymphoproliferative disorders

artículo científico publicado en 2009

Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.

artículo científico publicado en 2012

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

artículo científico publicado en 2007

International consensus report on the investigation and management of primary immune thrombocytopenia

artículo científico publicado en 2010

Is ITP a thrombophilic disorder?

artículo científico publicado en 2015

Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials

artículo científico publicado en 2013

Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia

artículo científico publicado en 2012

Multivariate statistical data analysis as a tool to analyze ex vivo expansion dynamics of cytokine-induced killer cells

artículo científico publicado en 2013

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

artículo científico publicado en 2011

Optimizing treatment of von Willebrand disease by using phenotypic and molecular data

artículo científico publicado en 2009

Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future

artículo científico publicado en 2016

Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

artículo científico publicado en 2004

Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations

artículo científico publicado en 2009

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

artículo científico publicado en 2006

Recurrence of the 'deep-intronic' FGG IVS6-320A>T mutation causing quantitative fibrinogen deficiency in the Italian population of Veneto

artículo científico publicado en 2009

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia ⬇️

artículo científico publicado el 11 de noviembre de 2010

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

artículo científico publicado en 2017

Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?

artículo científico publicado en 2012

Side effects of anti-angiogenic drugs

artículo científico publicado en 2012

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

artículo científico publicado en 2012

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

artículo científico publicado en 2008

TPO-receptor agonists in ITP: a clinician's navigation between Scylla and Charybdis

artículo científico publicado en 2012

The European Hematology Association Roadmap for European Hematology Research: a consensus document

artículo científico publicado en 2016

The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia

artículo científico publicado en 2013

The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases

artículo científico publicado en 2009

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience

artículo científico publicado en 2006

Treatment of immune thrombocytopenia in adults: the role of thrombopoietin-receptor agonists

artículo científico publicado en 2014

Treatment of von Willebrand disease

artículo científico publicado en 2005

Treatment practices in adults with chronic immune thrombocytopenia - a European perspective

artículo científico publicado en 2009

Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment

artículo científico publicado en 2003

Lista de obras de

A critical appraisal of the evidence for the role of splenectomy in adults and children with ITP.

A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene

A novel heterozygous missense mutation (His127Arg) in a family with inherited cross-reacting material positive factor XI deficiency

Advances in the diagnosis and management of type 1 von Willebrand disease ⬇️

Assessing bleeding in von Willebrand disease with bleeding score

Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C?

Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.

Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists.

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia

Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia

Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation

Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults

Economic assessment of eltrombopag in the treatment of thrombocytopenia

Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome

First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat

Flow cytometry in the diagnosis of drug-induced thrombocytopenia: two illustrative cases

Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature

Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from literature analysis

How I treat von Willebrand disease

ITP and international guidelines: what do we know, what do we need?

Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

Immune thrombocytopenia in lymphoproliferative disorders

Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.

Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia

International consensus report on the investigation and management of primary immune thrombocytopenia

Is ITP a thrombophilic disorder?

Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials

Low-dose alemtuzumab-associated immune thrombocytopenia in chronic lymphocytic leukemia

Multivariate statistical data analysis as a tool to analyze ex vivo expansion dynamics of cytokine-induced killer cells

Newly diagnosed immune thrombocytopenia in children and adults: a comparative prospective observational registry of the Intercontinental Cooperative Immune Thrombocytopenia Study Group

Optimizing treatment of von Willebrand disease by using phenotypic and molecular data

Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem/stromal cells: present and future

Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.

Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

Recurrence of the 'deep-intronic' FGG IVS6-320A>T mutation causing quantitative fibrinogen deficiency in the Italian population of Veneto

Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia ⬇️

Safety and efficacy of romiplostim in splenectomized and nonsplenectomized patients with primary immune thrombocytopenia

Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications?

Side effects of anti-angiogenic drugs

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

TPO-receptor agonists in ITP: a clinician's navigation between Scylla and Charybdis

The European Hematology Association Roadmap for European Hematology Research: a consensus document

The combination of rituximab, bendamustine, and cytarabine for heavily pretreated relapsed/refractory cytogenetically high-risk patients with chronic lymphocytic leukemia

The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases

Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience

Treatment of immune thrombocytopenia in adults: the role of thrombopoietin-receptor agonists

Treatment of von Willebrand disease

Treatment practices in adults with chronic immune thrombocytopenia - a European perspective

Von Willebrand's disease in the year 2003: towards the complete identification of gene defects for correct diagnosis and treatment